The week in 60 seconds
What happened, and nothing elseEight of eleven sectors fell, and five companies went up anyway.
- The S&P 500 fell 0.49 percent, the Russell 2000 fell 1.02 percent, and eight of eleven sectors finished lower.
- The August inflation print came in cooler than expected on September 30 and the 30 year Treasury yield still closed at 5.638 percent, the highest of the cycle.
- The three month bill yield fell nine basis points while the 30 year rose 14.2, a 23 basis point steepening in a single week.
- Accenture rose 19.67 percent on record bookings, United Therapeutics 21.00 percent on a patent ruling, and Carnival 15.05 percent on a record quarter.
- The risk I named last week fired eleven days early; the 30 year crossed 5.55 percent on September 28 and the damage spread well past the bond proxies.
You have the headline. The brief adds the market setup behind it, a line on each of the five, and what matters next. Continue to the 5-minute brief →
The 5-minute brief
~5 minMarket read
This was a down week that looked narrow and was actually something stranger. The S&P 500 fell 0.49 percent, the Russell 2000 fell 1.02 percent, and eight of eleven sectors finished lower against three the week before. The cause was the long end of the Treasury market: the 30 year yield rose 14.2 basis points to 5.603 percent after touching 5.638 on September 30, the highest close of this cycle. What makes that reading unusual is what happened the same morning. The August inflation report came in cooler than expected, 3.4 percent against a 3.7 percent forecast, the three month bill yield fell nine basis points across the week, and traders cut the odds of an October rate increase to about 37 percent. Good inflation news, and the long bond sold off anyway. That is a supply problem, not a price problem, and it is why two Treasury auctions next week matter more than any earnings release. Against that tape, the only things that rose were companies that produced dated, specific evidence in the same five sessions: a bookings record, a raised guidance range, a court ruling, a record quarter and a funded buyback. Nothing moved on a theme this week. Everything that moved, moved on a document.
Market Risk Score: 64 / 100 (Elevated).
The risk score grades overall market conditions from 0 (calm) to 100 (high risk). It sets how cautious the week's read is. It is not a signal to buy or sell anything.
The five
- 01ACN, view score cardAccentureRecord bookingsWeekly moveup 19.7 percent
Three things separate this from the rest of the screen.
- 02SNPS, view score cardSynopsysGuidance raisedWeekly moveup 15.4 percent
The design software companies sit at the front of every chip that gets built, which makes their guidance a better forward read on semiconductor capital spending than most semiconductor guidance.
- 03UTHR, view score cardUnited TherapeuticsPatent rulingWeekly moveup 21.0 percent
A patent ruling is the most literal form of proof a market can be handed, which is why it belongs in this issue.
- 04CCL, view score cardCarnival CorporationRecord quarterWeekly moveup 15.1 percent
This is the issue only read on the ordinary consumer, and it is a useful one because the rest of the consumer tape disagreed with it.
- 05TLN, view score cardTalen EnergyFunded buybackWeekly moveup 7.7 percent
Almost everything in the power and data centre complex this year has been a promise about demand in 2028.
Weekly move is each stock's movement during the window this issue analyzes (Week of September 24 to October 1, 2026), which closes before the issue publishes. It is not a return earned after publication. How each figure is measured →
What matters next
- Oct 2. The September employment report, 8:30 a.m. Eastern.
- Oct 5. The ISM services survey.
- Oct 7. A 10 year Treasury note reopening auction, and the minutes of the September Federal Open Market Committee meeting.
You have the briefing.
Full research adds:
- the evidence behind the market read, and what would break it
- the complete case and the bear case on all five
- the next dated event for each name, and what result confirms or ends the thesis
- the primary sources every claim rests on
- the calls this issue is willing to be graded on next week
Full research
~22 minWeek ahead: the full analysis
I expect the market to keep paying for a short list of companies that produced dated evidence and to keep taking it out of everything else. From the October 2 close to the October 9 close I expect the technology sector fund XLK to beat the equal weight S&P 500 fund RSP again, as it has in each of the last six weeks by 1.23, 1.62, 1.56, 2.23, 3.65 and 2.19 percentage points. The reason is the discount rate, and the reason the discount rate is rising is supply rather than inflation. On September 30 the August inflation print came in at 3.4 percent against a 3.7 percent expectation, the three month bill yield fell nine basis points across the week as the market priced October rate increase odds down to about 37 percent, and the 30 year yield rose 14.2 basis points anyway to close at 5.603 after touching 5.638, the highest close of this cycle. A long bond that will not rally on good inflation news is being sold by someone who has to sell it, and two reopening auctions land inside this window, a 10 year on October 7 and a 30 year on October 8. A rising term premium subtracts most from businesses whose cash flows are fixed and least from businesses growing fast enough to outrun it, and the average stock is the former. I put this at 66 percent rather than higher because the September employment report lands before the window opens and I am writing without it.
What would prove me wrong. The technology sector fund XLK trails the equal weight S&P 500 fund RSP by more than 1.5 percentage points from the October 2 close to the October 9 close, measured as the percentage change in XLK minus the percentage change in RSP. I put the odds of this view holding at 66%.
- Oct 2. The September employment report, 8:30 a.m. Eastern.
It lands the morning this issue is delivered, so nothing here is written with knowledge of it. A hot number puts the October rate increase back on the table and extends the sorting; a weak one is the fastest way the laggards get bid. - Oct 5. The ISM services survey.
The September 23 flash survey is what started this rate move. A second hot services reading says the September print was not a one off and keeps the pressure on the long end. - Oct 7. A 10 year Treasury note reopening auction, and the minutes of the September Federal Open Market Committee meeting.
Direct supply into a market that has sold off for three straight weeks, on the same day the market sees how much disagreement there was behind the September rate increase. - Oct 8. A 30 year Treasury bond reopening auction.
This is the one. The 30 year is the observable behind the whole week and behind the risk below. A weak auction extends everything in this issue; a strong one is what would reverse it. - Oct 14. The September consumer price index.
Outside this window, but it is the reading that decides whether the December rate increase the market has moved toward is real.
The biggest risk right now. The auctions go well and the long end finally retreats. Every week this year that the 30 year has backed off, the names that were sold on rates have rallied hard and the concentrated winners have gone sideways. A strong 10 year on October 7 and a strong 30 year on October 8 would do more damage to what I have just written than a weak one would, because the entire expectation rests on the discount rate continuing to sort the market. The 30 year yield has risen three weeks running to 5.603 percent and sits at the highest close of this cycle, which is where supply pressure is most visible and also where a buyer strike is most likely to end. The short end has already turned the other way: the three month bill yield fell nine basis points this week and October rate increase odds fell to about 37 percent from roughly a coin flip the day before. If the long end follows the short end down, utilities, real estate, financials and the Russell 2000, which have lagged for six straight weeks, are the first things bought. The 30 year Treasury yield closing below 5.45 percent on or before October 16, 2026. That is about 15 basis points below the October 1 close of 5.603 percent, a little over one standard deviation of a two week move in this observable. I put it at 25% by 2026-10-16.
Last week I said, and I was right
In Issue No. 14 I said the market would keep paying for a small number of companies and selling everything else, and that the cap weight S&P 500 would keep beating the equal weight version from the September 25 close to the October 2 close, because a rising discount rate sorts businesses by how fast their cash flows grow. I put it at 68 percent and said I would be wrong if the equal weight fund RSP beat the cap weight fund SPY by more than 1.0 percentage point. The kill condition never fired. RSP finished the window 0.05 percentage points behind SPY, and the closest it came to the trigger was 0.16 points on September 29. So the call survived. The mechanism I described did not. The cap weight lead I said would keep widening collapsed from 1.68 points to 0.18, and it collapsed for a reason that has nothing to do with my argument: three large companies in one sector fell, with Meta down 6.64 percent, Netflix down 5.40 percent and Alphabet down 1.20 percent. Breadth did not improve. The Russell 2000 fell 1.02 percent, more than either index measure, and eight of eleven sectors finished lower against three the week before. I was right about the result and wrong about the road, which is the kind of survival worth saying out loud. The risk I named is the part that deserves the attention: I said at 35 percent that the rate move would stop being selective, with the 30 year closing above 5.55 percent by October 9 as the confirming reading. It closed 5.561 on September 28, eleven days early, then 5.594 and 5.638. The risk I flagged is the thing that happened. I said I would be wrong if the equal weight index beat the cap weight index by more than 1.0 point. Its closest approach was 0.16 points on September 29, so the call cleared its own kill line by 0.84 points, about 0.6 standard deviations. That is a genuine survival rather than a near miss, but it is not a comfortable one, and the mechanism behind it failed even though the threshold held.
This week's five
ACN, view score card · Accenture · Technology / IT Services
- Move before publication
- +19.7%
Accenture reported fiscal fourth quarter results on October 1 and the shares rose 15.8 percent that session, finishing the week up 19.67 percent. Fourth quarter revenue was 18.68 billion dollars and diluted earnings per share 3.29 dollars, but the number that moved the stock was bookings: 22.17 billion dollars in the quarter and 84.54 billion dollars for the full year, an all time high. For most of 2026 this stock has been sold on one argument, that artificial intelligence would shrink the work it does. The bookings figure is the first hard reading against that argument, and it arrived with the stock down about 32 percent for the calendar year.
The catalyst. Accenture reported fourth quarter and full year fiscal 2026 results on October 1, 2026. Fourth quarter revenue was 18.68 billion dollars with diluted earnings per share of 3.29 dollars and new bookings of 22.17 billion dollars. Full year revenue was 74.18 billion dollars, full year diluted earnings per share 13.56 dollars, and full year new bookings 84.54 billion dollars, an all time high. The company guided fiscal 2027 to revenue growth of 3 to 6 percent in local currency, diluted earnings per share of 14.39 to 14.81 dollars, and at least 9.5 billion dollars returned to shareholders. The shares closed at 212.30 on October 1 against 177.41 on September 24. U.S. Securities and Exchange Commission, October 1, 2026
Why it made the five. Three things separate this from the rest of the screen. The move is one session and it is the session after the results, so the cause is not in dispute. The catalyst is a forward number rather than a backward one: bookings are work signed and not yet delivered, which is the only part of a consulting income statement that says anything about next year. And the setup was a genuine disagreement, not a crowded long. A company entering its print down 32 percent for the year while the index is up 12 percent is a company where the market has taken a position, and this is the week that position got tested by data.
What to watch next. Fiscal first quarter 2027 results, expected mid December though the company has not announced a date, the first quarter that tests whether the record bookings convert into the revenue growth the guidance does not yet assume Confirms the thesis: Bookings growth holds and management lifts the 3 to 6 percent fiscal 2027 revenue range Breaks it: Bookings decelerate, which would make this quarter a pull forward rather than a turn
The case against it. The guidance does not support the enthusiasm. Fiscal 2027 revenue growth was guided to 3 to 6 percent in local currency, slower than what fiscal 2026 just delivered, and guided shareholder returns of at least 9.5 billion dollars are below the record 11.5 billion dollars returned in fiscal 2026. Bookings are also the easiest figure in this business to flatter, because a large multi year renewal lands in one quarter and says nothing about pricing. At roughly 14.5 times the midpoint of its own fiscal 2027 earnings guidance the stock is no longer priced for disaster, so the discount that made this interesting is partly gone. And one quarter does not settle a structural argument about what automation does to billable hours.
Weekly move (before publication): +19.7%
Every ACN appearance →Track this pick on the Scoreboard →Size a position in it →
SNPS, view score card · Synopsys · Technology / Software
- Move before publication
- +15.4%
Synopsys held its 2026 investor day on September 30 and guided fiscal 2027 revenue to 11.1 to 11.2 billion dollars, about 15 percent growth and above the roughly 10.8 billion dollars the sell side had been carrying. It also set a long term model of about 50 percent non-GAAP operating margin by fiscal 2030, announced an intellectual property agreement with Amazon that makes Amazon the lead customer for a new application optimised intellectual property business, announced a chip design partnership with OpenAI, and said it intends to repurchase about 1 billion dollars of shares in the coming months. The shares rose 4.8 percent on the day and 12.8 percent the day after, closing the week up 15.45 percent.
The catalyst. At its 2026 investor day on September 30, 2026, Synopsys guided fiscal 2027 revenue to 11.1 to 11.2 billion dollars, about 15 percent year over year growth, against a prior analyst consensus near 10.8 billion dollars. It set a long term model of about 50 percent non-GAAP operating margin by fiscal 2030 with mid twenties non-GAAP earnings per share growth, announced an intellectual property agreement with Amazon covering custom silicon, announced a chip design partnership with OpenAI, and stated an intent to repurchase approximately 1 billion dollars of shares over the coming months with a long term objective of returning up to 50 percent of free cash flow through repurchases. The shares closed at 490.54 on October 1 against 424.91 on September 24. Synopsys, Inc., September 30, 2026
Why it made the five. The design software companies sit at the front of every chip that gets built, which makes their guidance a better forward read on semiconductor capital spending than most semiconductor guidance. What makes this a pick rather than a theme is that the number was raised against a published consensus, by a company that has historically guided conservatively, and the raise came with a named lead customer rather than a market size estimate. The comparison that matters is Cadence, which rose 6.2 percent on October 1 against 12.8 percent here on the same tape. The market treated this as company specific, and so do I.
What to watch next. Fiscal fourth quarter and full year fiscal 2026 results, expected in early December though the company has not announced a date, the first report after the new model was set Confirms the thesis: The fiscal 2027 range is reaffirmed with the Amazon arrangement quantified Breaks it: The company reiterates the long term targets without putting revenue behind either partnership
The case against it. Everything announced this week is a plan. Neither the Amazon agreement nor the OpenAI partnership carries a disclosed contract value, the fiscal 2030 margin objective is four years out, and the fiscal 2027 range is guidance the company has not yet had to defend against a reported quarter. The stock added 15 percent in two sessions for a four year model, which prices a meaningful part of that plan before any of it reaches the income statement. It now trades within about 9 percent of its 52 week high, so the margin for a disappointing fiscal fourth quarter in December is thin. And a customer concentration story that starts with one named lead customer is a concentration risk as much as a validation.
Weekly move (before publication): +15.4%
Every SNPS appearance →Track this pick on the Scoreboard →Size a position in it →
UTHR, view score card · United Therapeutics · Health Care / Biotechnology
- Move before publication
- +21.0%
On September 30 the United States District Court for the District of Delaware found that Liquidia Technologies infringes two claims of a United Therapeutics patent covering inhaled treprostinil for pulmonary hypertension associated with interstitial lung disease. United Therapeutics said it believes it is entitled to an order instructing the Food and Drug Administration to withdraw approval of the competing product, and that it intends to seek damages including a royalty on past sales. The shares rose 12.5 percent that session and 5.4 percent the next, finishing the week up 21.00 percent. That happened in a week when Health Care was the third weakest sector, down 2.16 percent.
The catalyst. On September 30, 2026 the United States District Court for the District of Delaware determined that Liquidia Technologies infringes claims 1 and 14 of United States Patent No. 11,826,327, which covers a method of improving exercise capacity in patients with pulmonary hypertension associated with interstitial lung disease by inhaling treprostinil at specified dosages. United Therapeutics stated it believes it is entitled to an order instructing the Food and Drug Administration to withdraw approval of the Liquidia new drug application for Yutrepia, and that it intends to seek monetary damages potentially including a royalty on past sales. The shares closed at 571.38 on October 1 against 472.21 on September 24. United Therapeutics Corporation, September 30, 2026
Why it made the five. A patent ruling is the most literal form of proof a market can be handed, which is why it belongs in this issue. It is also the cleanest case on the list for ruling out alternatives: two other United Therapeutics items circulated in the same period, the Food and Drug Administration accepting its idiopathic pulmonary fibrosis filing and an accelerated buyback, and both were announced in early September, before this measurement window opened. The ruling is the only dated event inside it. A 21 percent move in a sector that fell 2.16 percent is about as company specific as a week gets.
What to watch next. Third quarter results, expected in late October though the company has not announced a date. The one confirmed date ahead of it is April 26, 2027, the Food and Drug Administration target action date on the separate filing to extend nebulized Tyvaso into idiopathic pulmonary fibrosis Confirms the thesis: The court issues a remedy consistent with the company stated position and Liquidia exhausts its options Breaks it: The remedy falls short of withdrawal, or an appeal stays it
The case against it. A district court opinion is not a final judgment, and the market has priced one as if it were. The remedy has not been set, whether the Food and Drug Administration is actually instructed to withdraw the competing approval has not been decided, and an appeal is available. The sentence doing most of the work in the press release is the company stating what it believes it is entitled to, which is a litigation position rather than an order. Patent outcomes in this field have reversed on appeal before. The shares now sit about 6 percent below their 52 week high, so the price already assumes the best available version of a process that is not finished.
Weekly move (before publication): +21.0%
Every UTHR appearance →Track this pick on the Scoreboard →Size a position in it →
CCL, view score card · Carnival Corporation · Consumer Discretionary / Travel and Leisure
- Move before publication
- +15.1%
Carnival reported third quarter results on September 29 and the shares rose 13.4 percent that session, closing the week up 15.05 percent. Revenue was 8,435 million dollars, net income 1,920 million dollars and adjusted earnings per share 1.43 dollars, all records. Net yields reached 254.99 dollars per available lower berth day, up 2.4 percent in constant currency, and customer deposits reached 7.6 billion dollars, half a billion above a prior year record. The company raised full year adjusted earnings per share guidance to 2.24 dollars, an improvement of more than 150 million dollars in adjusted net income against June guidance despite a 150 million dollar fuel headwind. The shares entered that morning at 21.79, which is 34 cents above their 52 week low.
The catalyst. Carnival Corporation reported third quarter 2026 results on September 29, 2026. Revenue was 8,435 million dollars, net income 1,920 million dollars, adjusted net income 1,963 million dollars and adjusted diluted earnings per share 1.43 dollars. Net yields were 254.99 dollars per available lower berth day, up 2.4 percent in constant currency, and customer deposits were 7.6 billion dollars, up 0.5 billion dollars against a prior year record. The company raised full year 2026 adjusted earnings per share guidance to 2.24 dollars, representing more than 150 million dollars of operational improvement in adjusted net income against June guidance despite a 150 million dollar fuel headwind, and guided fourth quarter adjusted earnings per share to approximately 0.20 dollars. The shares closed at 25.07 on October 1 against 21.79 on September 24. U.S. Securities and Exchange Commission, September 29, 2026
Why it made the five. This is the issue only read on the ordinary consumer, and it is a useful one because the rest of the consumer tape disagreed with it. Consumer Discretionary fell 1.37 percent across the week, Walmart fell 3.10 percent and Home Depot fell 3.33 percent, and a cruise operator printed records anyway. Customer deposits are the reason I take it seriously: that figure is cash already paid for travel not yet taken, which makes it the closest thing in the consumer complex to a forward order book. The competing explanation, that this was a sector bounce, does not survive the sequence. Royal Caribbean rose 7.5 percent on the same day, roughly half as much, and only after Carnival opened.
What to watch next. Fourth quarter and full year results, expected in late December though the company has not announced a date, covering the fiscal year that ends November 30 Confirms the thesis: Customer deposits make another record and the fourth quarter clears the 0.20 dollar guide Breaks it: Deposits flatten, which would be the first sign the forward book is turning
The case against it. The guidance was not uniformly good. Fourth quarter adjusted earnings per share were guided to about 0.20 dollars against a consensus near 0.25 dollars, and the full year raise absorbs a 150 million dollar fuel headwind that has not gone away. The shares are still down about 18 percent for the calendar year and about 26 percent below their 52 week high, so this is a recovery from a depressed level rather than a breakout from strength, and the market has repeatedly treated record cruise results as a cycle peak rather than a trend. The business also carries real leverage into a week when the long end of the Treasury curve made a new cycle high, which is the least convenient backdrop a heavily financed operator can have.
Weekly move (before publication): +15.1%
Every CCL appearance →Track this pick on the Scoreboard →Size a position in it →
TLN, view score card · Talen Energy · Utilities / Independent Power
- Move before publication
- +7.7%
On September 29 Talen Energy named Terry Nutt chief executive officer effective January 1, 2027, and announced in the same release that it had entered 1.5 billion dollars of accelerated share repurchase agreements that day and upsized its total repurchase authorisation to 3.0 billion dollars through 2028. The company said the program is expected to retire more than 10 percent of its shares at current prices. It is funded in part by about 1.5 billion dollars of PJM capacity revenue monetisation for the 2027 to 2028 and 2028 to 2029 delivery years, completed four days earlier on September 25. The shares rose 7.69 percent across the week while the Utilities sector rose 0.81 percent.
The catalyst. On September 29, 2026 Talen Energy announced that its board named Terry L. Nutt chief executive officer and president effective January 1, 2027, with Mac McFarland remaining chief executive through December 31, 2026 and then serving as senior advisor until his retirement in March 2027. In the same announcement Talen entered 1.5 billion dollars of accelerated share repurchase agreements and upsized its total share repurchase authorisation to 3.0 billion dollars through 2028, which the company said is expected to retire more than 10 percent of shares at current prices and be accretive to free cash flow per share. The program is funded in part by approximately 1.5 billion dollars of PJM capacity revenue monetisation for the 2027 to 2028 and 2028 to 2029 delivery years, completed September 25, 2026. The shares closed at 323.09 on October 1 against 300.01 on September 24. U.S. Securities and Exchange Commission, September 29, 2026
Why it made the five. Almost everything in the power and data centre complex this year has been a promise about demand in 2028. This is the opposite: the company sold future capacity revenue on September 25 and spent 1.5 billion dollars of it buying its own stock four days later. Cash has moved and the share count is going down. In a week when the market was paying for evidence and ignoring narrative, that distinction is the whole reason this name is here rather than one of the larger independent power producers that moved on headlines.
What to watch next. Third quarter results, expected in early November though the company has not announced a date. The confirmed date is January 1, 2027, when the chief executive transition takes effect Confirms the thesis: The share count falls visibly in the third quarter filing and the repurchase program continues at pace Breaks it: The repurchase slows, or the capacity monetisation proceeds are redirected
The case against it. Monetising capacity revenue for the 2027 to 2028 and 2028 to 2029 delivery years converts future cash into present share count reduction. It raises per share figures without adding a megawatt of generation, and it leaves less cushion if power prices or PJM capacity prices move against the company in exactly those years. A chief executive transition announced alongside an active capital allocation program is its own execution risk, since the person who set the plan is not the person who will finish it. The stock is still down about 14 percent for the calendar year and about 28 percent below its 52 week high, and the 7.69 percent move is roughly the size of the share count reduction, which suggests the market took the arithmetic at face value and nothing beyond it. This is also the thinnest name in the issue at about 277 million dollars of average daily trading.
Weekly move (before publication): +7.7%
Every TLN appearance →Track this pick on the Scoreboard →Size a position in it →
Stock of the week
Accenture (ACN, view score card)
Stock of the Week is the most instructive name in the issue, not the largest weekly mover.
Accenture is the Stock of the Week because it is the clearest example of what this week was about. Going into October 1 the stock was down about 32 percent for the calendar year while the S&P 500 was up about 12 percent, a gap of more than 40 points, and the reason was a single argument: that artificial intelligence would eat the demand for technology consulting. That argument had never been tested against a number. On October 1 it was, and the number was 84.54 billion dollars of full year bookings, an all time high. The stock rose 15.8 percent in one session. The lesson is not that the bear argument was wrong, because one quarter does not settle a structural question, and the company own fiscal 2027 revenue guidance of 3 to 6 percent growth is slower than what it just reported. The lesson is about what a long, unresolved disagreement does to a price. When a stock has been sold for nine months on a thesis that nobody has been able to check, the first checkable piece of evidence moves it violently, in whichever direction it points.
Sector rotation
Into: Technology · Utilities · Energy · Industrials
Out of: Communication Services · Real Estate · Materials · Health Care
Rotation is money moving between industry groups. It shows where big investors added this week and where they pulled back.
Terms in this issue
Accelerated share repurchase. A deal in which a company pays a bank a large sum up front and immediately receives most of the shares it is buying back, instead of buying them gradually in the open market over months. The bank sorts out the actual purchasing afterwards. More in the Learn hub →
New bookings. The value of work a services company has signed but not yet performed. It is a forward indicator, because revenue in later quarters has to come out of it, though the timing and the profitability are not fixed when it is signed.
Term premium. The extra yield investors demand for lending money for thirty years instead of rolling over short loans. When it rises while inflation expectations fall, the bond market is worrying about supply and risk rather than about prices.
Bear steepener. A move in which long term interest rates rise faster than short term rates, so the gap between them widens while both ends are under pressure. It usually signals concern about government borrowing rather than about central bank policy.
Equal weight index. A version of an index that gives every company the same weighting, so the average company drives the result rather than the largest few. Comparing it with the standard index is the quickest way to see whether a market move is broad or narrow.
Net yield. For a cruise operator, the revenue earned per available bed per day after the costs directly tied to carrying that passenger. It separates genuine pricing power from simply sailing more ships.